CARE assigns ratings to Wockhardt’s bank facilities

20 Feb 2014 Evaluate

Credit rating agency, CARE has assigned  ‘AA-’ rating to Wockhardt’s long term bank facilities worth Rs 175 crore and ‘A1+’ rating to company’s Short term Bank Facilities worth Rs 82.50 crore.

The company has received the ratings on the back of its long track record, extensive experience of the promoters and well-established presence in the global pharmaceutical industry, its well-diversified product portfolio having established brands catering to multiple therapeutic segments and accredited manufacturing facilities supported with well equipped R&D facilities mainly in complex generics.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1345.90 -17.25 (-1.27%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×